Received May 12, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y013818 | IM / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | UNK | U8600AA | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CX4HL | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y013818 | OT / RA |
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | U8600AA | OT / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CX4HL | OT / RA |
No additional AE; temperature excursion; This Spontaneous report was received from a medical assistant and referred to an 11 -year-old Female patient. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 04-Feb-2026, the vaccines went through temperature excursion of 47.4F for 1 hours 0 minutes 0 seconds and 28.9F for 0 hours 45 minutes 0 seconds. On 06-Feb-2026, the patient was vaccinated with the first dose of Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) (Batch/Lot Number: Y013818 has been verified to be a valid lot number, Expiration date not reported, but upon internal validation established as: 12-Feb-2027) via Intramuscular in the Right arm; the first dose of Menquadfi (Meningococcal vaccine A/C/Y/W conj (tet tox)) (Batch/Lot Number: U8600AA, Expiration date: 31-Oct-2028; dose and strength were not reported) via Intramuscular in the left arm; the first dose of Boostrix (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Tetanus vaccine toxoid) (Batch/Lot Number: CX4HL, Expiration date: 09-Nov-2026; dose and strength were not reported) via Intramuscular in the right arm (Product storage error). All suspect vaccines were administered for prophylaxis. No additional AE (No adverse event).